Climb Bio (CLYM) Cash from Operations (2020 - 2026)
Climb Bio (CLYM) posted Cash from Operations of 14379000.0 for Q1 2026, up 8.03% on a QoQ basis from 15635000.0 in Q4 2025, and up 6.84% year-over-year from 13459002.12 in Q1 2025.
Climb Bio (CLYM) Cash from Operations (2020 - 2026) Analysis & Trends
Climb Bio's Cash from Operations history runs 7 years deep, the most recent figure standing at 14379000.0 for Q1 2026.
- Quarterly Cash from Operations rose 6.84% year-over-year to 14379000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 53301000.0 (down 82.68% YoY) and the FY2025 annual result came in at 54356000.0, down 249.29% from the prior year.
- Cash from Operations was 14379000.0 for Q1 2026 at Climb Bio, up from 15635000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 3490000.0 in Q3 2023 and bottomed at 15635000.0 in Q4 2025.
- A 5-year average of 8368529.41 and a median of 8449000.0 in 2022 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2023 — Cash from Operations jumped 183.59% — and 2025, when it slumped 1571.36%.
- Climb Bio's Cash from Operations stood at 8449000.0 in 2022, then soared by 88.79% to 947000.0 in 2023, then tumbled by 483.0% to 5521000.0 in 2024, then sank by 183.19% to 15635000.0 in 2025, then gained by 8.03% to 14379000.0 in 2026.
- Business Quant data shows CLYM's Cash from Operations at 14379000.0 in Q1 2026, 15635000.0 in Q4 2025, and 12139000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Climb Bio | 870.33 Mn | 870.33 Mn | - | -14.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.38 Mn |
| Mar 31, 2026 | -14.38 Mn |
| Dec 31, 2025 | -15.64 Mn |
| Dec 31, 2025 | -15.64 Mn |
| Sep 30, 2025 | -12.14 Mn |
| Sep 30, 2025 | -12.14 Mn |
| Jun 30, 2025 | -11.15 Mn |
| Jun 30, 2025 | -11.15 Mn |
| Mar 31, 2025 | -15.43 Mn |
| Mar 31, 2025 | -15.43 Mn |
| Dec 31, 2024 | -5.52 Mn |
| Dec 31, 2024 | -5.52 Mn |
| Sep 30, 2024 | -7.56 Mn |
| Sep 30, 2024 | -7.56 Mn |
| Jun 30, 2024 | -667,000.00 |
| Jun 30, 2024 | -667,000.00 |
| Mar 31, 2024 | -1.82 Mn |
| Mar 31, 2024 | -1.82 Mn |
| Dec 31, 2023 | -947,000.00 |
| Dec 31, 2023 | -947,000.00 |